Medicare Enrolled
Dr. Victor Ferlise, MD
Urology Physician · Toms River, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ferlise from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ferlise?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ferlise
Dr. Victor Ferlise is an urology physician in Toms River, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ferlise performed 13,071 Medicare services across 5,142 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ferlise received a total of $2,126 from 28 pharmaceutical and/or device companies across 118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ferlise is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in NJ
$2,126 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,071
Medicare services
Top 5% in NJ for urology physician
5,142
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~688 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 4,998 | $2 | $6 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
2,799 | $2 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,684 | $71 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,199 | $99 | $225 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 391 | $131 | $850 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
323 | $90 | $325 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
288 | $130 | $320 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
253 | $65 | $150 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
106 | $77 | $400 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
101 | $20 | $75 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
95 | $11 | $225 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
83 | $30 | $110 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
83 | $108 | $275 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
81 | $211 | $550 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $48 | $125 |
| Simple change of bladder tube | 65 | $80 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
62 | $138 | $275 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
48 | $96 | $600 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
42 | $26 | $325 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
42 | $24 | $245 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
36 | $102 | $800 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $148 | $375 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
23 | $477 | $2,800 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
22 | $46 | $75 |
| Bladder/urethra growth removal via endoscope, 0.5-2.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters. |
21 | $195 | $3,800 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
19 | $225 | $4,000 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
16 | $329 | $4,200 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
15 | $607 | $2,400 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
14 | $128 | $1,300 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
13 | $174 | $800 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
13 | $10 | $55 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
12 | $28 | $600 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
11 | $3 | $10 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
11 | $71 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
5.0% medium
94.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,126
Total received (2018-2024)
Avg $304/year across 7 years
Bottom 49% in NJ for urology physician
28
Companies
118
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,126 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$475
2023
$17
2022
$106
2021
$266
2020
$158
2019
$692
2018
$413
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$142
Medtronic, Inc.
$97
Edap Technomed Inc
$81
DENTSPLY IH AB
$60
Dendreon Pharmaceuticals LLC
$26
180 Medical, Inc.
$20
Boston Scientific Corporation
$16
ABBVIE INC.
$16
Antares Pharma, Inc.
$16
Top 3 companies account for 67.5% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$246
AbbVie Inc.
$235
AbbVie, Inc.
$161
PROCEPT BioRobotics Corporation
$142
NeoTract Inc.
$142
Dendreon Pharmaceuticals LLC
$139
ABBVIE INC.
$123
Medtronic, Inc.
$97
Astellas Pharma US Inc
$87
Edap Technomed Inc
$81
PFIZER INC.
$67
BOSTON SCIENTIFIC CORPORATION
$63
Bayer HealthCare Pharmaceuticals Inc.
$61
DENTSPLY IH AB
$60
Janssen Biotech, Inc.
$55
Boston Scientific Corporation
$53
Dornier MedTech America, Inc
$50
Avadel Specialty Pharmaceuticals, LLC
$42
COLOPLAST CORP
$39
Axonics, Inc.
$34
Antares Pharma, Inc.
$28
Blue Earth Diagnostics Limited
$27
Coloplast Corp
$25
180 Medical, Inc.
$20
Allergan Inc.
$13
Metuchen Pharmaceuticals
$13
Zyla Life Sciences
$13
Aytu BioScience, Inc
$12
Top 3 companies account for 30.2% of all-time payments
Associated products mentioned in payments ›
AMS · AMS 700 · AQUABEAM SYSTEM · Androgel · Axonics r-SNM System · Axumin · BOTOX · Bulkamid · Erleada · GENERAL ERECTILE DYSFUNCTION · INTERSTIM · LITHOVUE · LOFRIC · LUPRON DEPOT · Lithotripters & Accessories · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · Natesto · Noctiva · Nubeqa · PROVENGE · SENSOR · SPEEDICATH · SPRIX · SUTENT · SpeediCath · Stendra · UroLift · VESICARE · XTANDI · XYOSTED · Xofigo · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
50
Per 100K population
7.7
County median income
$86,411
Nearest hospital
COMMUNITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ferlise is a clinical cardiology specialist, with above-average Medicare volume (top 5% in NJ), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ferlise experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Ferlise performed 4,998 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ferlise receive payments from pharmaceutical companies?
Yes. Dr. Ferlise received a total of $2,126 from 28 companies across 118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ferlise's costs compare to other urology physicians in Toms River?
Dr. Ferlise's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ferlise) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Toms River
Browse urology physicians in Toms River ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology